The conversation is about organizing hair regrowth results using a standard format in a single post for easier access. Treatments mentioned include oral minoxidil, oral finasteride, and dermarolling.
The user shared progress pictures after 4 months of using 5% topical minoxidil and microneedling for hair loss. They discussed their positive results and experiences with these treatments.
A user underwent a second hair transplant for increased density and to address hair loss in the crown area, with 3,800 grafts at a cost of 2,200 euros at Estepalace, including additional services. Some commenters discussed the appearance of the hairline and the importance of using DHT blockers like finasteride or dutasteride post-transplant.
The user experienced significant hair regrowth using a regimen of topical Minoxidil and Finasteride, oral Finasteride, weekly microneedling, and supplements over a year. They noted improvements in the crown and temples, with minimal side effects, and plan to continue the regimen.
Microneedling alone may not be effective for hair regrowth, though it can improve skin and reduce scars. Minoxidil caused heart palpitations for one user, leading them to stop its use.
The user has been using a topical combination of finasteride and minoxidil for six months, with some progress noted. They also use Nizoral twice a week and plan to start microneedling.
The user has been using a topical combination of finasteride, minoxidil, and dermastamping for three months to address hair loss. They are considering adding tretinoin and are discussing the effectiveness of topical versus oral treatments.
The conversation discusses using USB microscopes for scalp photos and provides a link to an overview of trichoscopy. Treatments mentioned include Minoxidil, finasteride, and RU58841.
A user with diffuse thinning recommends a root cover-up spray as a temporary, medication-free solution. They plan to consult a dermatologist for treatments like Minoxidil and finasteride while using the spray for special occasions.
Kintor Pharma finished enrolling and dosing participants in a Phase I trial for a hair loss treatment called AR-PROTAC (GT20029). The effectiveness of another drug, pyrilutamide (KX-826), for hair loss will be clearer after a Phase 2 trial expected to complete in January 2023.